| Product Code: ETC7798665 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Kenya Cannabis Pharmaceutical Market Overview |
3.1 Kenya Country Macro Economic Indicators |
3.2 Kenya Cannabis Pharmaceutical Market Revenues & Volume, 2021 & 2031F |
3.3 Kenya Cannabis Pharmaceutical Market - Industry Life Cycle |
3.4 Kenya Cannabis Pharmaceutical Market - Porter's Five Forces |
3.5 Kenya Cannabis Pharmaceutical Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Kenya Cannabis Pharmaceutical Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.7 Kenya Cannabis Pharmaceutical Market Revenues & Volume Share, By Compound Type, 2021 & 2031F |
3.8 Kenya Cannabis Pharmaceutical Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 Kenya Cannabis Pharmaceutical Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Kenya Cannabis Pharmaceutical Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Kenya Cannabis Pharmaceutical Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing acceptance of cannabis for medical purposes due to its potential health benefits and therapeutic properties. |
4.2.2 Growing investment in research and development of cannabis-based pharmaceutical products in Kenya. |
4.2.3 Favorable regulatory environment and government support for the cannabis pharmaceutical industry in Kenya. |
4.3 Market Restraints |
4.3.1 Limited awareness and education among healthcare professionals and consumers about the benefits and safe usage of cannabis pharmaceutical products. |
4.3.2 Concerns about the misuse and abuse of cannabis-based medications leading to regulatory challenges and stigma. |
5 Kenya Cannabis Pharmaceutical Market Trends |
6 Kenya Cannabis Pharmaceutical Market, By Types |
6.1 Kenya Cannabis Pharmaceutical Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Kenya Cannabis Pharmaceutical Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Kenya Cannabis Pharmaceutical Market Revenues & Volume, By Capsules, 2021- 2031F |
6.1.4 Kenya Cannabis Pharmaceutical Market Revenues & Volume, By Concentrates, 2021- 2031F |
6.1.5 Kenya Cannabis Pharmaceutical Market Revenues & Volume, By Edibles, 2021- 2031F |
6.2 Kenya Cannabis Pharmaceutical Market, By Drugs |
6.2.1 Overview and Analysis |
6.2.2 Kenya Cannabis Pharmaceutical Market Revenues & Volume, By Epidiolex, 2021- 2031F |
6.2.3 Kenya Cannabis Pharmaceutical Market Revenues & Volume, By Marinol, 2021- 2031F |
6.2.4 Kenya Cannabis Pharmaceutical Market Revenues & Volume, By Cesamet, 2021- 2031F |
6.2.5 Kenya Cannabis Pharmaceutical Market Revenues & Volume, By Sativex, 2021- 2031F |
6.3 Kenya Cannabis Pharmaceutical Market, By Compound Type |
6.3.1 Overview and Analysis |
6.3.2 Kenya Cannabis Pharmaceutical Market Revenues & Volume, By Tetrahydrocannabinol (THC), 2021- 2031F |
6.3.3 Kenya Cannabis Pharmaceutical Market Revenues & Volume, By Cannabidiol (CBD), 2021- 2031F |
6.3.4 Kenya Cannabis Pharmaceutical Market Revenues & Volume, By Balanced THC & CBD, 2021- 2031F |
6.4 Kenya Cannabis Pharmaceutical Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Kenya Cannabis Pharmaceutical Market Revenues & Volume, By Inflammation, 2021- 2031F |
6.4.3 Kenya Cannabis Pharmaceutical Market Revenues & Volume, By Chronic Pain, 2021- 2031F |
6.4.4 Kenya Cannabis Pharmaceutical Market Revenues & Volume, By Epilepsy, 2021- 2031F |
6.4.5 Kenya Cannabis Pharmaceutical Market Revenues & Volume, By Sleep Disorders, 2021- 2031F |
6.4.6 Kenya Cannabis Pharmaceutical Market Revenues & Volume, By Anorexia, 2021- 2031F |
6.4.7 Kenya Cannabis Pharmaceutical Market Revenues & Volume, By Schizophrenia, 2021- 2031F |
6.5 Kenya Cannabis Pharmaceutical Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Kenya Cannabis Pharmaceutical Market Revenues & Volume, By Clinic, 2021- 2031F |
6.5.3 Kenya Cannabis Pharmaceutical Market Revenues & Volume, By Hospital, 2021- 2031F |
6.6 Kenya Cannabis Pharmaceutical Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Kenya Cannabis Pharmaceutical Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Kenya Cannabis Pharmaceutical Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Kenya Cannabis Pharmaceutical Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Kenya Cannabis Pharmaceutical Market Import-Export Trade Statistics |
7.1 Kenya Cannabis Pharmaceutical Market Export to Major Countries |
7.2 Kenya Cannabis Pharmaceutical Market Imports from Major Countries |
8 Kenya Cannabis Pharmaceutical Market Key Performance Indicators |
8.1 Number of clinical trials and research studies conducted on cannabis pharmaceutical products in Kenya. |
8.2 Growth in the number of licensed pharmaceutical companies investing in cannabis-based medicines. |
8.3 Percentage increase in healthcare professionals prescribing cannabis pharmaceuticals in Kenya. |
8.4 Patient satisfaction and reported health outcomes from using cannabis pharmaceutical products. |
8.5 Regulatory approvals and changes in policies related to the cannabis pharmaceutical market in Kenya. |
9 Kenya Cannabis Pharmaceutical Market - Opportunity Assessment |
9.1 Kenya Cannabis Pharmaceutical Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Kenya Cannabis Pharmaceutical Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.3 Kenya Cannabis Pharmaceutical Market Opportunity Assessment, By Compound Type, 2021 & 2031F |
9.4 Kenya Cannabis Pharmaceutical Market Opportunity Assessment, By Application, 2021 & 2031F |
9.5 Kenya Cannabis Pharmaceutical Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Kenya Cannabis Pharmaceutical Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Kenya Cannabis Pharmaceutical Market - Competitive Landscape |
10.1 Kenya Cannabis Pharmaceutical Market Revenue Share, By Companies, 2024 |
10.2 Kenya Cannabis Pharmaceutical Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here